AMRX Company Profile and Key Details
Amneal Pharmaceuticals, Inc.
AMRX Stock Price Chart
Stock Price Today
Amneal Pharmaceuticals, Inc. (AMRX) stock declined over -1.03%, trading at $8.18 on NYSE, down from the previous close of $8.26. The stock opened at $8.09, fluctuating between $8.01 and $8.28 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products with focus on central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers Emverm, a chewable tablet for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; Rytary to treat Parkinson's disease; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs. It is also involved in the wholesale distribution of bottle and unit dose pharmaceuticals under the AvKARE and AvPAK names, as well as medical and surgical products; and packaging and wholesale distribution of pharmaceuticals and vitamins to its retail and institutional customers. The company sells its products through wholesalers, distributors, hospitals, chain pharmacies, and individual pharmacies. It operates in the United States, India, Ireland, and internationally. The company was formerly known as Atlas Holdings, Inc. and changed its name to Amneal Pharmaceuticals, Inc. in 2018. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey.
Company Information
| Employees | 7850 |
| Beta | 1.18 |
| Sales or Revenue | $2.39B |
| 5Y Sales Change% | 0.047% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Frequently Asked Questions
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) stock price is $8.18 in the last trading session. During the trading session, AMRX stock reached the peak price of $8.28 while $8.01 was the lowest point it dropped to. The percentage change in AMRX stock occurred in the recent session was -1.03% while the dollar amount for the price change in AMRX stock was -$0.09.
The NYSE listed AMRX is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector. Amneal Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Sanjiv Patel
Senior Vice President of Operations
Dr. Nikunj Patel
Head of Ops & Executive Vice President of Amneal Pharmaceuticals (India) Pvt Ltd
Mr. Sanjay Kumar Jain Ph.D.
Pres of India Operations
Dr. Srinivas Kone Ph.D.
Senior Vice President of Global Generic R&D
Mr. Chirag K. Patel
Co-Founder, Co-Chief Executive Officer, Pres & Director
Mr. Chintu Patel R.Ph, R.Ph.
Co-Founder, Co-Chief Executive Officer & Director
Mr. Anastasios G. Konidaris
Executive Vice President & Chief Financial Officer
Mr. Jason B. Daly Esq.
Senior Vice President, Chief Legal Officer & Corporation Sec.
Ms. Nikita Shah
Executive Vice President & Chief HR Officer
Mr. Andrew S. Boyer
Executive Vice President & Chief Commercial Officer of Generics
Mr. Anthony DiMeo
Senior Director of Investor Relations
Mr. Gregory Sgammato
Senior Vice President of Corporation Devel.
Mr. Pranav Mehta
Senior Vice President of Strategic Sourcing & Supply Management
AMRX's closing price is 64.87% higher than its 52-week low of $5.01 where as its distance from 52-week high of $9.48 is -12.82%.
Number of AMRX employees currently stands at 7,850.
Official Website of AMRX is: https://www.amneal.com
AMRX could be contacted at phone 908 947 3120 and can also be accessed through its website. AMRX operates from 400 Crossing Boulevard, Bridgewater, NJ 08807, United States.
AMRX stock volume for the day was 944.5K shares. The average number of AMRX shares traded daily for last 3 months was 1.18M.
The market value of AMRX currently stands at $3.78B with its latest stock price at $8.18 and 461.96M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com